Inhalation Sciences to present at Redeye Life Science Day November 11
(Stockholm, 4 November, 2021) Inhalation Sciences (ISAB) CEO Manoush Masarrat will present the latest developments for the company at Redeye Life Science Day on November 11. ISAB provide high-precision equipment and research services for aerosol and inhalation studies that can de-risk drug development projects.
Redeye Life Science Day is a digital event where up to 50 companies will present their business and technologies, and take questions from analysts and experts.
The presentation is live broadcasted and can be followed at: https://www.redeye.se/events/815899/redeye-life-science-day-2021.
The presentation will also be available at www.redeye.se and on ISAB’s website: https://www.inhalation.se/investors/presentationer/
For more information on Inhalation Sciences, please contact:
Manoush Masarrat, CEO
E-mail: Manoush.masarrat@inhalation.se
Mobile: +46 (0)73 628 9153
About Inhalations Sciences Sweden AB (publ)
Inhalation Sciences Sweden AB (publ) develops and commercializes world-leading instruments and services for research into inhalation. The company’s patented lab instruments PreciseInhale® and DissolvIt® enable researchers in the pharma industry to make drug pipeline decisions at an early stage, saving time and resources for R&D departments, and enables researchers in academic institutions to define how aerosols and small particles impact our lungs, and so our health, when being inhaled.
Tags: